AJP - Renal Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 287: F886-F895, 2004. First published July 27, 2004; doi:10.1152/ajprenal.00123.2004
0363-6127/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/5/F886    most recent
00123.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (15)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, J.
Right arrow Articles by Guan, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, J.
Right arrow Articles by Guan, Y.

Liver X receptor-{alpha} mediates cholesterol efflux in glomerular mesangial cells

Jing Wu,1 Yahua Zhang,2 Nanping Wang,1 Linda Davis,2 Guangrui Yang,1 Xian Wang,1 Yi Zhu,1 Matthew D. Breyer,2 and Youfei Guan1,2

1Department of Physiology and Pathophysiology, Peking University Health Science Center, Beijing 100083, People's Republic of China; and 2Division of Nephrology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee 37212

Submitted 6 April 2004 ; accepted in final form 30 June 2004

Lipid-mediated injury plays an important role in the pathogenesis of many renal diseases including diabetic nephropathy. Liver X receptor-{alpha} (LXR{alpha}) is an intracellular sterol sensor that regulates expression of genes controlling cholesterol absorption, excretion, catabolism, and cellular efflux. The present study was aimed at examining the role of LXR{alpha} in cholesterol metabolism in glomerular mesangial cells. A 1,561-bp fragment of full-length rabbit LXR cDNA was cloned. The deduced protein sequence exhibited 92.4 and 89.2% identity to human and mouse LXR{alpha}, respectively. Tissue distribution studies showed that rabbit LXR{alpha} was expressed in the liver, spleen, and kidney. In situ hybridization and RT-PCR assays further indicated that LXR{alpha} mRNA was widely expressed in the kidney and present in every nephron segment including the glomeruli. To determine intrarenal regulation of LXR{alpha}, rabbits were treated with thiazolidinedione (TZD) peroxisome proliferator-activated receptor-{gamma} (PPAR{gamma}) agonists, which have been previously shown to enhance LXR{alpha} expression via PPAR{gamma} and increase cholesterol efflux in macrophages. The results showed that glomerular LXR{alpha} expression was markedly induced by TZDs. In cultured rabbit mesangial cells, LXR{alpha} mRNA and protein were detected by RT-PCR and immunoblotting. Treatment of mesangial cells with a specific LXR{alpha} agonist, TO-901317, significantly increased basal and apolipoprotein AI-mediated cholesterol efflux and markedly enhanced the promoter activity of an LXR{alpha} target gene, ATP-binding cassette transporter A1 (ABCA1). In conclusion, LXR{alpha} is expressed in renal glomeruli and functionally present in mesangial cells where its activation mediates cholesterol efflux via ABCA1. These data suggest that LXR{alpha} may be a potential therapeutic target for treating lipid-related renal glomerular disease.

glomeruli; ATP-binding cassette transporter A1



Address for reprint requests and other correspondence: Y. Guan, Div. of Nephrology, S-3223 MCN, Vanderbilt Univ. Medical Ctr., Nashville, TN 37232-2372 (E-mail: youfei.guan{at}vanderbilt.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
H. J. Kim, H. Moradi, J. Yuan, K. Norris, and N. D. Vaziri
Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney
Am J Physiol Renal Physiol, June 1, 2009; 296(6): F1297 - F1306.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
X. Ruan, F. Zheng, and Y. Guan
PPARs and the kidney in metabolic syndrome
Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1032 - F1047.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
C. J Delvecchio and J. P Capone
Protein kinase C {alpha} modulates liver X receptor {alpha} transactivation
J. Endocrinol., April 1, 2008; 197(1): 121 - 130.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
C. Farke, E. Viturro, H. H. D. Meyer, and C. Albrecht
Identification of the bovine cholesterol efflux regulatory protein ABCA1 and its expression in various tissues
J Anim Sci, November 1, 2006; 84(11): 2887 - 2894.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
Y. Zhang, X. Zhang, L. Chen, J. Wu, D. Su, W. J. Lu, M.-T. Hwang, G. Yang, S. Li, M. Wei, et al.
Liver X receptor agonist TO-901317 upregulates SCD1 expression in renal proximal straight tubule
Am J Physiol Renal Physiol, May 1, 2006; 290(5): F1065 - F1073.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. K. Berfield, A. Chait, J. F. Oram, R. A. Zager, A. C. Johnson, and C. K. Abrass
IGF-1 induces rat glomerular mesangial cells to accumulate triglyceride
Am J Physiol Renal Physiol, January 1, 2006; 290(1): F138 - F147.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
Y. Wang, A. H. Moser, J. K. Shigenaga, C. Grunfeld, and K. R. Feingold
Downregulation of liver X receptor-{alpha} in mouse kidney and HK-2 proximal tubular cells by LPS and cytokines
J. Lipid Res., November 1, 2005; 46(11): 2377 - 2387.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. F. Oram and J. W. Heinecke
ATP-Binding Cassette Transporter A1: A Cell Cholesterol Exporter That Protects Against Cardiovascular Disease
Physiol Rev, October 1, 2005; 85(4): 1343 - 1372.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.